Nexalin Technology Inc. Net Assets
Nexalin Technology Inc. net assets. Based on the latest financial reports, Nexalin Technology Inc. (NXL) has net assets worth $1.52 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.00 Million) and total liabilities ($1.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Nexalin Technology Inc. (NXL) equity growth momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.52 Million |
| % of Total Assets | 50.58% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 24.03 |
Net Assets of Nexalin Technology Inc. (2019–2025)
Net assets of Nexalin Technology Inc. from 2019 to 2025. This chart illustrates how Nexalin Technology Inc.'s net assets have evolved over time, based on quarterly financial data. See how leveraged is Nexalin Technology Inc.'s balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for Nexalin Technology Inc. (2019–2025)
The table below shows the annual net assets of Nexalin Technology Inc. from 2019 to 2025. For live market cap and overall valuation, see Nexalin Technology Inc. stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $3.75 Million | +1.96% |
| 2024-12-31 | $3.68 Million | +14.64% |
| 2023-12-31 | $3.21 Million | -41.47% |
| 2022-12-31 | $5.48 Million | +425.74% |
| 2021-12-31 | $-1.68 Million | -5.76% |
| 2020-12-31 | $-1.59 Million | -34.85% |
| 2019-12-31 | $-1.18 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nexalin Technology Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3165737800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Nexalin Technology Inc. Net Assets Breakdown (December 2025)
Nexalin Technology Inc. net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $19.19K | 0.51% |
| Other Comprehensive Income | $406.00 | 0.01% |
| Other Components | $96.60 Million | 2577.27% |
| Total Equity | $3.75 Million | 100.00% |
Nexalin Technology Inc. Competitors by Market Cap
The table below lists competitors of Nexalin Technology Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Magnetite Mines Ltd
AU:MGT
|
$1.25 Million |
|
MEP Infrastructure Developers Limited
NSE:MEP
|
$1.25 Million |
|
Kezar Life Sciences Inc
NASDAQ:KZR
|
$1.26 Million |
|
Inotiv Inc
NASDAQ:NOTV
|
$1.26 Million |
|
Biomx Inc
NYSE MKT:PHGE
|
$1.25 Million |
|
Uniinfo Telecom Services Limited
NSE:UNIINFO
|
$1.25 Million |
|
MFC Industrial Real Estate Investment Trust
BK:MIT
|
$1.25 Million |
|
Baroyeca Gold & Silver Inc
V:BGS
|
$1.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nexalin Technology Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,676,038 to 3,747,986, a change of 71,948 (2.0%).
- Net loss of 8,222,181 reduced equity.
- New share issuances of 4,646,397 increased equity.
- Other comprehensive income increased equity by 919.
- Other factors increased equity by 3,646,813.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-8.22 Million | -219.38% |
| Share Issuances | $4.65 Million | +123.97% |
| Other Comprehensive Income | $919.00 | +0.02% |
| Other Changes | $3.65 Million | +97.3% |
| Total Change | $- | 1.96% |
Book Value vs Market Value Analysis
This analysis compares Nexalin Technology Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.22x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-4.86 | $1.51 | x |
| 2020-12-31 | $-6.55 | $1.51 | x |
| 2021-12-31 | $-6.93 | $1.51 | x |
| 2022-12-31 | $22.56 | $1.51 | x |
| 2023-12-31 | $13.08 | $1.51 | x |
| 2024-12-31 | $11.97 | $1.51 | x |
| 2025-12-31 | $6.86 | $1.51 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nexalin Technology Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -219.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2725.76%
- • Asset Turnover: 0.07x
- • Equity Multiplier: 1.24x
- Recent ROE (-219.38%) is below the historical average (-86.04%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -2421.22% | 1.84x | 0.00x | $-4.90 Million |
| 2020 | 0.00% | -1401.11% | 2.05x | 0.00x | $-3.24 Million |
| 2021 | 0.00% | -4218.93% | 0.19x | 0.00x | $-5.91 Million |
| 2022 | -30.99% | -128.49% | 0.18x | 1.36x | $-2.25 Million |
| 2023 | -144.97% | -4197.56% | 0.03x | 1.13x | $-4.97 Million |
| 2024 | -206.94% | -4508.73% | 0.04x | 1.15x | $-7.97 Million |
| 2025 | -219.38% | -2725.76% | 0.07x | 1.24x | $-8.60 Million |
Industry Comparison
This section compares Nexalin Technology Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $755,718,394
- Average return on equity (ROE) among peers: -219.62%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nexalin Technology Inc. (NXL) | $1.52 Million | 0.00% | 0.98x | $1.25 Million |
| Abbott Laboratories (ABT) | $7.43 Billion | 32.93% | 0.95x | $191.55 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $2.37 Million |
| Aethlon Medical Inc (AEMD) | $595.41K | -1222.01% | 1.90x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $903.35K |
| Adapthealth Corp (AHCO) | $24.31K | -2.84% | 11.78x | $800.36 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $1.53 Million | -361.86% | 1.36x | $2.43 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $1.63 Million |
| Artivion Inc (AORT) | $20.50 Million | 10.73% | 0.15x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $37.79 Million | -61.34% | 0.37x | $109.52 Million |
About Nexalin Technology Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 a… Read more